Home Other Building Blocks CA-074

CA-074

CAS No.:
134448-10-5
Catalog Number:
AG009ATG
Molecular Formula:
C18H29N3O6
Molecular Weight:
383.4394
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
99%
1 week
United States
$207
- +
5mg
99%
1 week
United States
$507
- +
10mg
99%
1 week
United States
$707
- +
Product Description
Catalog Number:
AG009ATG
Chemical Name:
CA-074
CAS Number:
134448-10-5
Molecular Formula:
C18H29N3O6
Molecular Weight:
383.4394
MDL Number:
MFCD00797531
IUPAC Name:
(2S)-1-[(2S,3S)-3-methyl-2-[[(2S,3S)-3-(propylcarbamoyl)oxirane-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carboxylic acid
InChI:
InChI=1S/C18H29N3O6/c1-4-8-19-15(22)13-14(27-13)16(23)20-12(10(3)5-2)17(24)21-9-6-7-11(21)18(25)26/h10-14H,4-9H2,1-3H3,(H,19,22)(H,20,23)(H,25,26)/t10-,11-,12-,13-,14-/m0/s1
InChI Key:
ZEZGJKSEBRELAS-PEDHHIEDSA-N
SMILES:
CCCNC(=O)[C@H]1O[C@@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@H](CC)C
Properties
Complexity:
596  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
5  
Defined Bond Stereocenter Count:
0
Exact Mass:
383.206g/mol
Formal Charge:
0
Heavy Atom Count:
27  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
383.445g/mol
Monoisotopic Mass:
383.206g/mol
Rotatable Bond Count:
9  
Topological Polar Surface Area:
128A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.9  
Literature
Title Journal
Cathepsin B regulates the appearance and severity of mercury-induced inflammation and autoimmunity. Toxicological sciences : an official journal of the Society of Toxicology 20141201
Cathepsin B inhibition limits bone metastasis in breast cancer. Cancer research 20120301
An alternative metabolic pathway of amyloid precursor protein C-terminal fragments via cathepsin B in a human neuroglioma model. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20111001
Cathepsin B-mediated autophagy flux facilitates the anthrax toxin receptor 2-mediated delivery of anthrax lethal factor into the cytoplasm. The Journal of biological chemistry 20100115
[Structure-based drug development and medical/biological application of cathepsin specific inhibitors]. Seikagaku. The Journal of Japanese Biochemical Society 20091101
Intra- versus extracellular effects of microglia-derived cysteine proteases in a conditioned medium transfer model. Journal of neurochemistry 20090901
Identification of 3-acetyl-2-aminoquinolin-4-one as a novel, nonpeptidic scaffold for specific calpain inhibitory activity. Journal of medicinal chemistry 20090514
Voltage-gated Sodium Channel Activity Promotes Cysteine Cathepsin-dependent Invasiveness and Colony Growth of Human Cancer Cells. The Journal of biological chemistry 20090327
[The experimental study of specific inhibitor-CA-074Me of Cathepsin B suppressing retinal neovascularization]. [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 20080301
Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo. Clinical and experimental immunology 20061001
Identification and discrimination of extracellularly active cathepsins B and L in high-invasive melanoma cells. Analytical biochemistry 20060601
High-temperature liquid chromatography coupled on-line to a continuous-flow biochemical screening assay with electrospray ionization mass spectrometric detection. Analytical chemistry 20051215
Endosomal proteolysis of insulin-like growth factor-I at its C-terminal D-domain by cathepsin B. FEBS letters 20050815
The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition. Proceedings of the National Academy of Sciences of the United States of America 20050726
Differential susceptibility of metastatic and primary oral cancer cells to TRAIL-induced apoptosis. International journal of oncology 20050101
Crystal structure of NS-134 in complex with bovine cathepsin B: a two-headed epoxysuccinyl inhibitor extends along the entire active-site cleft. The Biochemical journal 20040715
Cathepsin L is crucial for a Th1-type immune response during Leishmania major infection. Microbes and infection 20040401
Significant accumulations of cathepsin B and prolylendopeptidase in inflammatory focus of delayed-type hypersensitivity induced by Mycobacterium tuberculosis in mice. Biochemical and biophysical research communications 20040326
Cysteine proteases and cell differentiation: excystment of the ciliated protist Sterkiella histriomuscorum. Eukaryotic cell 20031201
Cathepsin B in osteoblasts. Biochimica et biophysica acta 20030502
Primate neurons show different vulnerability to transient ischemia and response to cathepsin inhibition. Acta neuropathologica 20020901
Structural basis for development of cathepsin B-specific noncovalent-type inhibitor: crystal structure of cathepsin B-E64c complex. Biochimica et biophysica acta 20020603
CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells. Biological chemistry 20020101
Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications. The American journal of pathology 20011201
Properties